OLN Olin Corp
Healthcare · Chemicals & Allied Products
Olin Corp (OLN) is a healthcare company in the Chemicals & Allied Products industry, with a market capitalization of $2.5 billion. Shares last traded at $22.00, 27.8% below their 52-week high. Over the past year the stock is up 11.4%. Net profit margin is -1.5%, above the peer median of -5.8%. Revenue grew 3.7% year over year. The shares yield 5.5% in dividends.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q1 2026 | $-0.73 | 2026-05-08 |
| FY 2025 | $-0.88 | 2026-02-20 |
| Q3 2025 | $0.37 | 2025-10-28 |
| Q2 2025 | $0.00 | 2025-07-29 |
| Q1 2026 | $0.01 | 2026-05-08 |
| FY 2025 | $0.91 | 2026-02-20 |
Chemicals & Allied Products peers
OLN vs 14 industry peers (Chemicals & Allied Products), by market cap.
| SOLS | Solstice Advanced Materials Inc. | $13.6B | — | — | — | +0.61% |
| PRM | Perimeter Solutions, Inc. | $6.2B | -29.87 | 9.44 | -31.6% | +6.00% |
| BCPC | Balchem Corp | $5.3B | 34.44 | 5.14 | 14.9% | +1.06% |
| CC | Chemours Co | $3.3B | -8.48 | 0.56 | -6.6% | -1.18% |
| NGVT | Ingevity Corp | $2.6B | -15.28 | 2.19 | -14.3% | +2.36% |
| OLN | Olin Corp | $2.5B | -24.78 | 0.37 | -1.5% | -4.37% |
| HUN | Huntsman Corp | $2.1B | -7.45 | 0.37 | -5.0% | -5.23% |
| IOSP | Innospec Inc. | $2.0B | 17.48 | 1.15 | 6.6% | -0.47% |
| FMC | Fmc Corp | $1.4B | -0.64 | 0.42 | -64.6% | -3.67% |
| ECVT | Ecovyst Inc. | $1.4B | -19.71 | 1.94 | -9.8% | -0.62% |
| CITR | CitroTech Inc. | $157M | -4.25 | — | — | +14.94% |
| ACNT | ASCENT INDUSTRIES CO. | $126M | 145.27 | 1.68 | 1.2% | +0.69% |
| LOOP | Loop Industries, Inc. | $40M | -3.27 | — | — | -4.45% |
| SLI | Standard Lithium Ltd. | — | — | — | — | -1.01% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.